Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Competition
Pharma
Analysts pin high hopes early on Lilly's Foundayo launch
Meanwhile, Novo Nordisk—intent on keeping hold of its first-mover advantage in the obesity pill space—is mounting a proactive defense of oral Wegovy.
Fraiser Kansteiner
Apr 2, 2026 11:42am
Europe's pharma policy overhaul inches closer with new deal
Dec 11, 2025 4:20pm
Novo plots board shake-up after stalemate in leadership talks
Oct 21, 2025 11:36am
Amgen owes Regeneron $407M after defeat in PCSK9 antitrust suit
May 15, 2025 3:52pm
CSL Vifor floats £23M offer to end competition probe in UK
Dec 10, 2024 4:11pm
Teva hit with €463M fine over Copaxone misconduct claims in EU
Oct 31, 2024 10:45am
